Introduction
============

Dengue is a systemic viral infection with a significant socioeconomic and disease burden in many tropical and subtropical regions all over the world. Using cartographic approaches, one recent estimate indicates 390 million dengue infections per year (95% credible interval 284-528 million), of which 96 million (95% credible interval 67-136 million) manifest clinically (with any severity of disease) [@B01].

The etiologic agent of this tropical disease is dengue virus (DENV), member of the family Flaviviridae, with four different antigenic serotypes (DENV-1 to -4). The DENV genome of plus strand RNA encodes three structural proteins (capsid, prM and envelope) and seven non-structural proteins (NS1, NS2a, NS2b, NS3, NS4a, NS4b y NS5) [@B02],[@B03]

According to the PAHO, in 2013, for America reported 2,386,836 cases of dengue; of which 37,898 (1.6%) corresponded to severe dengue, with case fatality rate 0.06. Colombia, Andean country, reported 127,219 cases of dengue (55% of cases reported in Andean Sub-region); of which 3,377 (81.1% of cases reported in Andean Sub-region) corresponded to severe dengue [@B04].

Clinical and epidemiological observations showed that dengue disease severity may vary according to age, ethnicity, genetic factors, immune status and underlying disease. It may also depend on the co-circulation of DENV serotypes and reinfection by different DENV serotypes [@B05]-[@B09]. In this respect, it has been proposed the involvement of DENV infection-derived oxidative stress on the severity of dengue. This is based on their ability to trigger the release of proinflammatory cytokines, including TNF-alpha, participating in collective action in the immunopathogenesis of dengue disease [@B10].

By definition, oxidative stress is an imbalance between pro-oxidants and antioxidants in favour of the pro-oxidants [@B11], [@B12]. Instead, nitrosative stress is defined as an indiscriminate nitrosilation of biological molecules [@B13]. In the absence of an appropriate compensatory response from endogenous antioxidant defense system, the activation of several stress-sensitive intracellular signaling pathways have been reported. This activation involves the production of gene products that can lead to cell death and/or pathophysiological conditions [@B13] -[@B16].

The effects of DENV-derived oxidative stress and redox imbalance on human and animal cell cultures have been explored. The NO, ROS, and reactive nitrogen species-RNS levels, GSSG/GSH ratio, iNOS gene expression and phosphorylation of STAT-1 were increased during *in vitro* infection [@B17]-[@B26].

Recently, Olagnier *et al*., [@B27] have reported that nuclear factor-erythroid 2-related factor 2/Nrf-2 mediated oxidative stress response, iNOS signaling and production of NOS and ROS pathways were stimulated by DENV-2 infection of human monocyte-derived dendritic cells/Mo-DC. Also, a statistically significance decrease in SOD-2 mRNA levels was observed during treatment with ROS scavenger diphenyleneiodonium-DPI. In addition, these authors reported that DENV-2 infection was associated with NADPH oxidase-generated ROS accumulation.

These lines of evidence suggest that oxidative/nitrosative stress can be related to production of pathogenesis-related protein, increased susceptibility of mice to DENV infection, hemorrhage development in mice, proinflammatory cytokines and transcriptional factor expression, and DENV replication in various cell cultures.

Considering the aforementioned scenario, we performed a systematically review of observational studies evaluating the role of oxidative-nitrosative stress in pathogenesis of dengue. This review is important because understanding the involvement of oxidative and nitrosative stress in dengue pathogenesis could have potential implications for prognosis and treatment.

Materials and Methods
=====================

Search strategy
---------------

This review was guided by the standard PRISMA protocol (Preferred Reporting Items for Systematic Reviews and Meta-analysis) [@B28] and was registered on PROSPERO, an international database of prospectively registered systematic reviews in health and social care managed by Center for Review and Dissemination, University of York, on 12 November 2014; <http://www.crd.york.ac.uk/PROSPERO> (CRD42014014878). PubMed, EMBASE, The COCHRANE library, ScienceDirect, Scopus, SciELO, LILACS via Virtual Health Library, Google Scholar databases were searched for articles using a combination of descriptors to select the studies of interest.

Study selection
---------------

After finding previously published studies in the databases with the descriptors \"dengue\" OR \"dengue virus\" combined with \"oxidative stress\" OR \"nitrosative stress\" OR \"antioxidants\" OR \"oxidants\" OR \"free radicals\" OR \"oxidized lipid products\" OR \"lipid peroxides\" OR \"superoxide dismutase\" OR \"thioredoxin reductase\" OR \"nitric oxide\" OR \"nitric oxide synthase\", we performed an analysis on the inclusion/exclusion criteria. This electronic search strategy was supplemented by scanning the reference lists of all articles to identify additional studies that may have been missed during the initial search.

As inclusion criteria, we used observational studies that evaluated oxidative-nitrosative stress in dengue pathogenesis. Exclusion criteria were impossible extraction of data, no control group, dates from mosquito cells cultures, the editorial, comments, case reports, letter to the editor, conference abstract, review articles, proteomics, *in vitro* and *in vivo* studies. When multiple publications from the same study population were available, we included the most recent publication.

Additionally, two authors reviewed the studies independently in case of disagreement a third author was consulted. In this systematic review, there is no restriction regarding to language, publication period, patient age (children or adult), or study design.

Data extraction strategy
------------------------

Articles were selected for review by title and abstract. After reading full-text articles, we extracted data relating to study design, original purposes, sample size, main outcomes, methods, and oxidative stress markers values.

The systematic computerized literature search of published observational studies was carried out in June 2014.

Results
=======

Identification of studies
-------------------------

In total, 4,331 non-duplicates articles were identified from electronic databases searches, of which 16 were eligible for full text searching ([Fig. 1](#f01){ref-type="fig"}). [Table 1](#t01){ref-type="table"} presents the citation, definitions and characteristics of each included studies, respectively.

Figure 1.Flow diagram of studies included in the systematic review.

Table 1.Observational evidences of oxidative and nitrosative stress involvement in dengue pathogenesisStudy: author, Country, ReferenceStudy DesignOriginal purposesSample sizeOutcomesRay, India, 50Case-controlTo evaluate the status of antioxidants, enzymes of hepatic and muscular origin and other biochemical indicators in children with dengue illness at admission66 children with dengueSOD: ↑Patients vs. Controls (*p* \<0.005)(45 days to 12 yrs )25 healthy childrenGPx: ↓ Patients vs. Controls (*p* \<0.005)Follow-up period: noneValero, Venezuela, 34Case-controlTo determine the serum concentration of NO in patients with DF and DHF105 patients with dengueNitric oxide:53 healthy individuals↑ DF vs. DHF (p \<0.01)(Age-matched controls)↑ DF vs. Controls (p \<0.01)Follow-up period: noneGil, Cuba, 39Case-controlTo study the status of some oxidative stress markers in serologically confirmed adults dengue patients comparing with those observed in healthy individuals22 adults with dengueTAS (day 7): ↑ Patients vs. Controls (*p* \<0.05)(21 to 58 yrs)22 healthy individualsPP - SOD - MDA/4-HAD (days 3-5-7): ↑ Patients vs. Controls (*p* \<0.05)(Sex- and age-matched controls)Follow-up period: 7 daysTHs - GPx (days 3-5-7): ↓ Patients vs. Controls (*p* \<0.05)Klassen, Guatemala, 40Case-controlTo report data of several micronutrients with antioxidants in patients with classic dengue fever during the acute phase and convalescence from the disease and from appropriate reference control subjects9 adults with dengueRetinol: ↓ Patients (DI+DII) vs. Controls (*p* \<0.05)(18 to 68 yrs)Retinol (patients): ↓ DI vs. DIII (*p* \<0.05)12 healthy individualsb-carotene: ↓ DII vs. DIII (p= 0.03)Follow-up period:GSH: ↓ DII vs. DI (*p*= 0.02)DI: admission to the hospitalGSH (at DIII): ↓ Patients vs. Controls (*p* \<0.05)DII: 5 days after admission (discharge)TBARS (DI+DII): ↑ Patients vs. Controls (*p* \<0.05)DIII: 7 days after admissionTBARS (at DIII): ↑ Patients vs. Controls (*p* \<0.05)TAS (DI vs. DII): ↓ Patients vs. Controls (p= 0.01)Trairatvorakul, Thailand, 35Case-controlTo correlate nitric oxide levels in three groups with different severity ranging from DF, DHF I/II, to DSS, and to compare the results with a control group110 children with dengueNitric oxide:(\<15 yrs)↓ Patients vs. Controls (p \<0.05)38 healthy children↑DF vs. DHF I/II (p \<0.05)(Age-matched controls)↓ DHF I/II vs. DSS (p \<0.05)Follow-up period: noneRojas, Colombia, 51Cross-sectional studyTo evaluate the association between the levels of glutathione peroxidase and the manifestations and complications of dengue161 patients with dengueGPx:(6 to 85 yrs)↑ Patients with hemorrhages vs Patients without hemorrhages (p= 0.03)Chareonsirisuthigul, Thailand, 25Cross-sectional studyTo investigate the effect of antibody-dependent enhancement infection on pro- and anti-inflammatory cytokines production60 children with dengueNitric oxide (secondary DHF):(5 to 10 yrs)↓ Fever day vs. Convalescent day (p \<0.05)Soundravally, India, 48Case-controlTo assess whether oxidative stress induced changes in plasma protein can be an early predictor of severe dengue disease80 patients with dengue (26-53 yrs)PCO:↑ Patients vs. Controls (p \<0.001)63 healthy individuals↓ DF vs. DHF (p \<0.05)↓ DF vs. DSS (p \<0.05)↓ DHF vs. DSS (p \<0.05)(Sex- and age-matched controls)PBSH:↓ Patients vs. Controls (p \<0.001)Follow-up period: none↑ DF vs. DHF (p \<0.05)↑ DF vs. DSS (p \<0.05)Soundravally, India, 41Case-controlTo investigate the association of lipid peroxidation and protein carbonylation with thrombocytopenia in the different clinical spectrum of dengue infection80 patients with dengue (26-53 yrs)MDA (3-5-7 days):↑ Patients vs. Controls (p \<0.05)63 healthy individuals↓ DF vs. DSS (p \<0.05)MDA (5-7 days):(Sex- and age-matched controls)↓ DF vs. DHF (p \<0.05)PCOs (7 day):Follow-up period:↑ Patients vs. Controls (p \<0.001)TAS (3-5-7 days):7 days↓ DSS vs. Controls (p \<0.05)Mendes-Ribeiro, Brazil, 36Case-controlTo investigate the effects of DF on the platelet L-arginine-NO pathway, platelet function and an inflammatory acute-phase protein fibrinogen16 patients with DFTotal rates of ~L~-arginine transport and ~L~-arginine transport via system y^+^L:(35 ± 4 yrs)↑ DF vs. Controls (p \<0.05)18 healthy controlsTotal NOS activity:(Age-matched controls)↑ DF vs. Controls (p \<0.05)Follow-up period: noneSeet, Singapore, 45Case-controlTo investigate oxidative stress during dengue infection28 patients with denguePlasma HETEs:(23-68 yrs)↑ Febrile stage vs. Controls (p \<0.05)↑ Febrile stage vs. Convalescent stage (p \<0.05)28 healthy controlsCOPs:↓ Febrile stage vs. Controls (p \<0.05)(Age-matched controls)Urinary F~2~-IsoPs:↑ Febrile stage vs. Controls (p \<0.05)Follow-up period: 25 days↑ Febrile stage vs. Convalescent stage (p \<0.05)Lee, Singapore, 46Case-controlTo provide further insight into the relation between lipid oxidation products and human diseases35 patients with dengue (25-86 yrs)Plasma free F~2~-IsoPs:↑ DF onset vs. Controls (p \<0.01)↑ DF onset vs. DF recovery (p \<0.01)47 healthy controlsUrinary F~2~-IsoPs:↑ DF onset vs. Controls (p \<0.01)↑ DF onset vs. DF recovery (p \<0.01)(Age-matched controls)Plasma total HETEs:↑ DF onset vs. Controls (p \<0.01)↑ DF onset vs. DF recovery (p \<0.01)Follow-up period: noneCOPs:↓ DF onset vs. Controls (p \<0.05)↓ DF onset vs. DF recovery (p \<0.05)Levy, Venezuela, 28Cross-sectional studyTo compare the serum levels of IL-6, TNFa, IL-1b, NO, CRP, C3 and apoptosis in DENV-infected patients and in monocytes/macrophages cultures36 patients with DFNitric oxide:↑ DF vs. Controls (p \<0.001)(3-53 yrs)↑ DF vs. DHF (p \<0.001)↑ Primary infection vs. Controls (p \<0.001)34 patients with DHF↑ Secondary infection vs. Controls (p \<0.001)(3-53 yrs)↓ Primary infection vs. Secondary infection (p \<0.001)Matsuura, Brazil, 37Case-controlTo investigate ~L~-arginine transport as well as activity and expression of iNOS in DHF platelets23 patients with DHF (33±14 yrs)~L~-arginine transport via system y^+^L:25 healthy individuals↑ DHF vs. Controls (p \<0.05)(Age-matched controls)Total NOS activity:Follow-up period: none↑ DHF vs. Controls (p \<0.05)Gil, Cuba, 44Case-controlTo study the status of an extensive array of redox indexes as proposal of an integral and dynamic characterization of redox status22 patients with dengueMDA - HPO - SOD - PP: ↑ Patients vs. Controls (*p* \<0.05)(18-84 yrs)194 healthy individualsGSH:(Age-matched controls)↓ Patients vs. Controls (p \<0.05)Follow-up period: 7 daysSoundravally, India, 13Case-controlTo evaluate the levels of plasma MDA, TNF-a and IFN-g during defervescence, in all the three clinical groups of dengue compared to uninfected blood samples81 patients with dengueMDA:(16-67 yrs)↓ DF vs. DHF (p \<0.001)30 healthy individuals↓ DF vs. DSS (p \<0.001)(Sex- and age-matched controls)↓ DHF vs. DSS (p= 0.017)Follow-up period: none[^2]

Overview of included studies
----------------------------

**Country of origin.** Data from the observational research originate from India (n= 4), Thailand (n= 2), Singapore (n= 2), Cuba (n= 2), Guatemala (n= 1), Brazil (n= 2), Venezuela (n= 2), and, Colombia (n= 1).

**Study design**. Case-control study was the type of design most common in studies reviewed.

**Age.** The observational studies could be classified by the age range of participants: children (under 10 yrs, n= 1), adolescents (10 to 19 yrs, n= 1), children and adolescents (n= 1), adults (greater 19 yrs, n= 7), adolescents and adults (n= 3), children, adolescents and adults (n= 2), and age range: not reported (n= 1).

**Follow-up time.** Approximately 63% of observational studies reported a 7-day follow-up period. About a quarter of the included studies did not report follow-up of participants.

**Dengue case classification system**. The 1997 World Health Organization (WHO) dengue case classification criteria were used in all studies included in this review.

As indicated in [Table 2](#t02){ref-type="table"}, lipid peroxidation products (malondialdehyde-MDA, and hydroperoxides-THs), protein carbonyls (PCOs), antioxidant enzymes (superoxide dismutase-SOD, and glutathione peroxidase-GPx), nitric oxide, and reduced glutathione (GSH) levels were determined spectrophotometrically or spectroflurometrically using commercial and non-commercial assays. The most analyzed oxidative-nitrosative stress markers were lipid peroxidation products (35.7%; 10/28), antioxidant enzymes (17.9%; 5/28), and nitric oxide (10.7%; 3/28).

Table 2.Comparison of methods used and values reported in reviewed studies.MarkersMethodsReported valuesReferencesNOSpectrophotometric detectionAbsorbance at 540 nm. (Griess reagent)DF cases (DENV-1): 57.4 ± 3.02 mM34DF cases (DENV-4): 55.6 ± 2.25 mMDHF cases (DENV-2): 13.87 ± 2.05 mMDHF cases (DENV 4): 14.33 ± 1.25 mMControls: approx. 25 mMAbsorbance at 540 nm. (Commercial kit, Griess method)DF cases: approx. 40 mM28DHF cases: approx. 22 mMControls: approx. &lt;10 mMDF cases: 124.94 ± 36.79 mM35DHF I/II cases: 99.69 ± 33.42 mMDHF III/IV cases: 120.63 ± 46.26 mMControls: 168.18 ± 24.10 mMMDAAbsorbance at 532 nm. (Satoh method)Dengue cases: 4.9 ± 0.9 mM13Controls: 1.9 ± 0.4 mMAbsorbance at 586 nm. MDA + 4-HDA. (Commercial kit)Dengue cases: approx. 10-18 mM39Controls: approx. &lt;10 mMDifference in absorbances at 532 and 572 nm. (Jentzsch method)Dengue cases: 0.624 ± 0.144 mM40Controls: 0.450 ± 0.116 mMAbsorbance at 532 nm. (Satoh method)Dengue cases: approx. 2-8 mM41Controls: approx. 2 mMTHSAbsorbance at 560 nm. Oxidation of Fe(II) to Fe (III) by THs. (Commercial kit)Dengue cases: approx. 50-150 mM39Controls: approx. 200-280 mMAbsorbance at 560 nm. Oxidation of Fe(II) to Fe (III) by THsDengue cases: 119.6 ± 34.61 mM44Controls: 70.3 ± 13.9 mMPCOsAbsorbance at 366 nm. (Method of Levine)Dengue cases: approx. 3.0-8.0 nmol/mg protein41Controls: approx. 2.0-2.5 nmol/mg proteinDF cases: 4.98 ± 0.47 nmol/mg protein48DHF cases: 5.95 ± 0.61 nmol/mg proteinDSS cases: 6.66 ± 0.70 nmol/mg proteinControls: 1.97 ± 0.56 nmol/mg proteinSODAbsorbance at 505 nm. (commercial kit)DENV cases: approx. 1.8-3.0 U/ml39Controls: approx. 1.2-1.7 U/mlDENV cases: 2.26 ± 0.71 U/mg Hb44Controls: 1.41 ± 0.72 U/mg HbAbsorbance at 480 nm. (Epinephrine method)DF: 26.85 ± 8.13 U/ml50DHF: 23.17 ± 9.98 U/mlDSS: 24.86 ± 9.22 U/mlControls: 2.31 ± 0.97 U/ml[^3]

Discussion
==========

To our knowledge, no previous reviews on the involvement of oxidative-nitrosative stress in dengue pathogenesis have been performed. In the present systematic review, 16 articles concerning this subject were included.

The role of nitric oxide as strong immunomodulator and its association with viral infections, both *in vivo* and *in* *vitro*, have been clearly demonstrated [@B29], [@B30] but there are incongruous results in some studies in DENV-infected patients. For example, although elevated serum levels of nitric oxide have been observed in sera of patients with dengue fever (DF) in comparison to age-matched healthy controls [@B25], [@B31] or to patients with dengue hemorrhagic fever (DHF) [@B25], Trairatvorakul *et al*. [@B32], reported that serum nitric oxide levels were significantly higher in healthy children than in DF or DHF patients. These studies were characterized by the low case/control ratio ((1:0.5).

Now, the two first reports are consistent with high total nitric oxide synthase activity and high L-arginine transport via system y^+^L reported in platelet obtained from DF and DHF patients compared with healthy adult controls [@B33],[@B34].

A study by Thai investigators reported that nitric oxide levels of primary and secondary DF, and primary DHF were not significantly different on the fever, defervescent or convalescent days in plasma of 37 DENV-infected children, while the level of serum nitric oxide was significantly lower on the fever day than on the defervescent day among children with secondary DHF. In addition, serum nitric oxide levels had an inverse correlation with the level of DENV viraemia in patients with secondary DHF [@B22], but have not been linked to viral serotype infection [@B31].

These observations are consistent with the findings of Yen *et al*., [@B17], who reported a temporal coincidence between iNOS upregulation and free radical production with hemorrhage development in DENV-infected mice.

Blood nitrite and nitrate levels are frequently assessed as an index of systemic nitric oxide production. The spectrophotometric assay based on the Griess reagent is the most commonly used method to determine nitrite/nitrate concentration in biological matrixes [@B35]. In the [Table 2](#t02){ref-type="table"}, the contrasting results may be explained by differences in nitrate reduction and deproteinization methods used or by differences in characteristics of populations studied.

As regard lipid peroxidation products as biomarkers for oxidative stress, several studies have found high serum levels of MDA and 4-hydroxyalkenals (4-HAE) in dengue patients in comparison to healthy adult controls [@B10], [@B36] -[@B38]. Furthermore, others reported high serum MDA concentrations in DHF and dengue shock syndrome (DSS) patients than in DF patients. They also reported a positive correlation between serum MDA and TNF-α levels in all DENV-infected patients [@B10].

Interestingly, a recent study reported that DENV-2-infected mice showed alterations in oxidative stress by increasing the level of malondialdehyde (MDA) [@B18]. These data together provide direct evidence for use end products of lipid peroxidation as prognostic biomarker in dengue disease.

Similar concentrations of MDA were reported using Satoh method [@B10], [@B38]. Both patients and healthy controls, Klassen *et al*. [@B37], reported lower serum levels of MDA using Jentzch correction method. Instead, Gil *et al*. [@B36], reported high serum MDA concentrations in dengue patients. This sensible difference could be explained by detection of MDA in combination with 4-HAE and/or sensitivity and reproducibility of the method [@B39].

Although THs levels are considered a measure of overall oxidative damage [@B40], there are no consistent pattern of THs in dengue disease. Gil *et al*., [@B36] reported that serum THs concentrations were significantly decreased in dengue patients than in healthy adults. By contrast, the same group researchers recently reported elevated serum THs levels in dengue patients in comparison to adult controls [@B41]. In dengue cases, unlike controls, both studies reported similar serum THs concentrations.

Other oxidized lipid biomarkers have been studied. For example, isoprostanes (IsoPs), hydroxyeicosatetraenoic acid products (HETEs) and cholesterol oxidation products (COPs).

During febrile stage of dengue infection, high concentrations of urinary F~2~-IsoP and plasma HETEs levels have been detected in comparison with convalescent stage and also with healthy adults [@B42]. No significant differences were found in: (i) total F~2~-IsoPs levels in all three dengue infection phases in comparison to adult controls [@B42], [@B43], (ii) urinary F~2~-IsoPs and plasma HETEs levels between defervescence and convalescence phases [@B42], and (iii) total F~2~-IsoPs concentrations between onset of DF and recovery stage of DF. However, elevated plasma total HETEs levels and reduced COPs levels were observed in onset of DF than in recovery stage of DF or in controls [@B43].

With respect to PCOs content, it has been used as an important biomarker of protein oxidative damage in oxidative stress-related diseases in humans [@B44]. Elevated serum PCOs levels have been reported in dengue patients in comparison to adult controls. Moreover, elevated serum PCOs concentrations were associated with dengue disease severity [@B38], [@B45]. In both studies reported similar serum PCOs levels using method of Levine.

By definition, oxidative stress also involves the antioxidant defensive system which is formed by ROS protective enzymes (SOD, GPx, glutathione reductase-GR, Catalase-CAT, thioredoxin-TRX system, antioxidant nutrients, etc.), reactive oxygen species (ROS) scavengers (GSH, albumin, ascorbic acid, and uric acid), and sequestration of transition metal ions (transferrin, ferritin, metallothionein and ceruloplasmin) [@B46].

At all ages, elevated serum SOD levels and reduced GPx levels have been reported in dengue patients in comparison with controls [@B36], [@B41], [@B47]. By contrast, no differences were found in plasma antioxidants nutrients (except of retinol) concentrations between dengue patients and adult controls, but in this study only 9 patients and 12 healthy controls were evaluated [@B37].

Results of one study have shown that serum GPx levels were associated with spontaneous bleeding events and with serum triglycerides levels in dengue patients. This finding suggests that the intensity of oxidative stress can influence the clinical presentation of dengue [@B48]. In this regard, a recent study reported that increased triglycerides levels were observed mainly in severe dengue patients [@B49]. Based on these data, it is likely that serum lipid profile in DENV-infected patients plays an important role in dengue severity.

Free radical production and alterations in antioxidants status occur during dengue disease [@B37]. The major antioxidant defense system appears to function by scavenging radical free radical. Non-enzymatic scavenger like GSH has been shown to be an effective protector against oxidative damage [@B46]. There are differences in the reports on the comparison of GSH concentrations in dengue patients and healthy controls. Gil *et al*. [@B36], and Klassen *et al*. [@B37], reported that serum GSH levels were not significantly different between patients and controls, whereas Gil *et al*. [@B41] reported that serum GSH concentrations were significantly lower in dengue patients than in healthy adults controls. It is important to note two aspects: (i) these three researches were conducted in Central America and the Caribbean countries and (ii) the number of patients studied was small (n (22).

Despite the limitations of systematic reviews of observational studies, given the evidences presented here, oxidative-nitrosative stress is demonstrated by changes in plasma levels of nitric oxide, antioxidants, lipid peroxidation and protein oxidation markers in patients with dengue infection.

Additionally, elevated serum PCOs and MDA levels appear to be associated with dengue disease severity, expressed in terms of the 1997-WHO dengue case classification system. Accordingly, more data are needed to establish an association between oxidative-nitrosative stress and dengue severity in the context of 2009-WHO dengue classification scheme.

Conclusions
===========

Based on published data found in peer-reviewed literature, oxidative and nitrosative stress are demonstrated by changes in plasma levels of nitric oxide, antioxidants, lipid peroxidation and protein oxidation markers in patients with dengue infection. Additionally, elevated serum protein carbonyls and malondialdehyde levels appear to be associated with dengue disease severity.

There have been many studies that target the severity of dengue infections. However, our understanding is not complete yet. Better understanding of relation between oxidative-nitrosative stress and dengue pathogenesis will lead us to developing better prognostic strategies of this pathology.
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